Does a Virtual Program for Pelvic Pain Improve Pain and Sexual Outcomes in Individuals With Provoked Vestibulodynia?
Launched by QUEEN'S UNIVERSITY · May 22, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying whether a 3-month online program can help improve pain and sexual wellbeing in women suffering from a condition called provoked vestibulodynia, which is a type of chronic vulvar pain. The researchers want to find out how effective the program is in reducing pain and anxiety related to that pain, and they will compare the experiences of women who start the program right away with those who wait to begin. Participants will be able to go through the program at their own pace, learn about pain management, do specific exercises, and share their feelings about their pain and sexual health before, during, and after the program.
To be eligible for this trial, participants must be women aged 18 and older with a self-reported diagnosis of provoked vestibulodynia that has lasted for at least three months and causes a certain level of pain. Participants should live in North America and be fluent in English. Those who are pregnant, breastfeeding, or have certain health conditions that make daily activities challenging will not be included. This trial is not yet recruiting participants, but it aims to provide valuable insights that could help many women manage their pain better.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Self-reported physician diagnosis of provoked vestibulodynia (PVD)
- • PVD duration of at least 3 months
- • PVD pain intensity rating of at least 3 on a scale from 0 (no pain) to 10 (extreme pain)
- • Resides in North America (Canada or the United States)
- • Fluent in English
- Exclusion Criteria:
- • Less than 18 years old
- • Pregnancy or suspected pregnancy
- • Breastfeeding
- • Up to one year postpartum
- • Physical or mental health conditions that significantly interfere with activities of daily living
About Queen's University
Queen's University is a distinguished research institution located in Kingston, Ontario, Canada, known for its commitment to advancing knowledge and innovation in the health sciences. As a clinical trial sponsor, Queen's University fosters a collaborative environment that bridges academic research and clinical practice, aiming to enhance patient care and outcomes through rigorous scientific investigation. The university actively engages in a wide range of clinical studies, leveraging its expertise in diverse therapeutic areas to contribute to the development of new treatments and interventions. With a focus on ethical standards and regulatory compliance, Queen's University is dedicated to ensuring the integrity and reliability of its clinical research initiatives.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Caroline Pukall, PhD
Principal Investigator
Queen's University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported